MyFinsight
Home
Blog
About
Payments to line of credit
accounts receivable,...
-$740K
Proceeds from issuance of
stock and exercise of...
$11K
(-95.60%↓ Y/Y)
Inventories, net
-$1,054K
(-142.30%↓ Y/Y)
Accrued expenses
$972K
(-25.29%↓ Y/Y)
Deferred revenue
$772K
(122.69%↑ Y/Y)
Accounts payable
$392K
(117.80%↑ Y/Y)
Depreciation and
amortization
$323K
(-28.38%↓ Y/Y)
Stock-based compensation
$79K
(-68.02%↓ Y/Y)
Net cash (used in)
provided by financing...
$751K
(-93.66%↓ Y/Y)
Net cash provided by
(used in) operating...
$191K
(102.43%↑ Y/Y)
Canceled cashflow
$3,401K
(decrease) increase in cash
$473K
(-82.47%↓ Y/Y)
Canceled cashflow
$469K
Trade accounts
receivable, net
$2,966K
(-52.01%↓ Y/Y)
Net income (loss)
-$354K
(-112.89%↓ Y/Y)
Change in right of use
asset and lease...
-$61K
(79.25%↑ Y/Y)
Prepaid expenses and
other assets
$20K
(-97.96%↓ Y/Y)
Net cash used in
investing activities
-$469K
(63.22%↑ Y/Y)
Acquisition of equipment and
leasehold improvements
$469K
(-63.22%↓ Y/Y)
Back
Back
Cash Flow
SOLESENCE, INC. (SLSN)
SOLESENCE, INC. (SLSN)
source: myfinsight.com